Global in vitro diagnostics market is expected
to propagate at a significant rate owing to the surging incidences of rising
aging population, chronic lifestyle related diseases, and increased usage of
personalized medicine and point-of-care testing. In vitro diagnostics is
anticipated to grow due to the developments, innovation, and advancements in
various IVD technologies. Rising health concerns and the ability of the
consumers to take these IVD tests at home and in hospital have increased their
awareness among the consumers, leading to market growth. Serious health issues
including diabetes, cancer, and sexually transmitted diseases are expected to
be identified using IVD tests and surge the growth of the market in the long
run.
Increased
awareness among the consumers about various diseases, quickly altering
healthcare environment, and enhanced role of diagnostics in patient care has
provided a boost to the in vitro diagnostic market. Surging need for detecting
communicable diseases, point-of-care recognition, and identification of various
diseases like respiratory infections, RSV, influenza, and pneumonia along with
identification of pathogens causing filariasis and malaria are some of the key
drivers of IVD market.
To request a
sample copy or view summary of this report, click the link below:
Further key findings from the study suggest:
- Product-wise the in vitro diagnostic market is segmented into instruments, services, data management systems, reagents, and kits that are intended to diagnose and determine the state of health to mitigate, cure, prevent, or treat a particular disease. The Food and Drug Administration (FDA) classifies the IVD products according to regulatory control into Class I, II and III. Different techniques of carrying out IVD tests are molecular diagnostics, blood testing, diabetes testing, clinical chemistry, microbiological diagnostic techniques and flow cytometry. The tissue diagnostic market is expected to rise owing to the increasing incidents of lung and bronchus cancer, melanoma, and prostate breast cancer diagnosis. In 2013, Professional IVD products were the largest segment accounting for revenue of USD 36,117.3 million in 2013.
- Electrolyte panel, basic metabolic panel, lipid profile, liver panel, renal profile, rapid tests, western blot, hematology, coagulation, hemostasis, microarray, hybridization, radioimmunoassay and specialty chemicals are the most commonly used technologies in the market. Applications of in vitro diagnostics include oncology, cancer, nephrology, cardiology, drug testing, autoimmune diseases, diabetes and infectious diseases. The IVD tests are being used by a wide range of customers including academic institutes, in point-of-care testing, patient self-testing, hospitals, and laboratories.
- Region-wise the global IVD market is segmented into various regions including North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In 2014, North America was the largest regional segment with about 43% market share owing to established distribution channels, extraordinary diagnostics in cancer screening, and prevalent disorders like respiratory diseases and genetic testing. IVD market in Europe follows the lead and is expected to rise on account of rising cases of cancer, tuberculosis and pneumonia. However, Asia Pacific and China will follow the IVD market trend owing to the rising population and increasing disposable incomes.
See More
Reports of This Category:
About
Grand View Research:
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
sales@grandviewresearch.com
No comments:
Post a Comment